Meet the group

PharmAccess is a group of non-profit organizations dedicated to improving access to quality healthcare in Africa. PharmAccess mobilizes public and private resources for the benefit of doctors and patients through clinical standards and quality improvements, loans for healthcare providers, health insurance, mHealth innovations and operational research.

This integrated approach is made possible by the following organizations:

Visit website
Visit website
Visit website
Visit website
Country Offices

 Country Offices

 

Ghana
Kenya
Nigeria
Tanzania
Contact
  • Who we are
  • Our approach
  • News & Publications

PharmAccess Foundation
AHTC, Tower 4C
Paasheuvelweg 25
1105 BP Amsterdam
The Netherlands

T: +31 (0)20 2103920
E: info@pharmaccess.org

  • Who we are
  • Our approach
  • News & Publications
Newsroom

PharmAccess and partners launch mobile screening app for TB

Nigeria ranks as one of 14 countries with the highest-burden for tuberculosis (TB) and Drug-Resistant Tuberculosis (DR-TB). In 2019, Nigeria contributed 8% of the total of 4.3 million missed cases globally. An estimated 70% of tuberculosis cases are missed annually due to under-diagnosis, weak surveillance, lack of universal health coverage, and inefficient linkage between health care providers.

  • Jun 30, 2020
Suggested reads
  • Apr 13, 2022
    Cabinet Secretary for health, hon. Mutahi Kagwe lauds digital innovations as key to scaling health services to majority of Kenyans
  • Apr 07, 2022
    Maximising the Value of Health Data for Public Good: The Health Data Governance Principles
  • Dec 16, 2021
    Advance alternative financing mechanisms for universal health coverage in Nigeria

In an effort to solve this problem, PharmAccess collaborated with the National Tuberculosis and Leprosy Control Programme (NTBLCP) and the Institute of Human Virology Nigeria (IHVN) to design a mobile application for easy screening and diagnosis of tuberculosis cases by private health care providers.

Mobile Application for Tuberculosis Screening (MATS) is designed to align with the national TB algorithm. Whilst taking into consideration the needs of community pharmacists, patent medicine vendors, traditional birth attendants, faith-based organizations, and private-for-profit facilities who play a critical role in the screening of clients and referring them to designated facilities for diagnosis and/or treatment.

Njide Ndili, Nigerian Country Director at PharmAccess, explains, “Our goal in developing MATS was to leverage digital and mobile innovations to scale up tuberculosis screening and treatment in order to reduce the disease burden in Nigeria. Working with the Global Fund, the National Tuberculosis Programme, and other key stakeholders, we are delighted to see the mobile application lead the process to finally eradicate the scourge of tuberculosis in Nigeria.”

The Chief Executive Officer of IHVN, Dr. Patrick Dakum, shared “The MATS launch this month is a game-changer in the provision of real-time and online information on progress made by private-for-profit facilities, faith-based organization facilities, patent medicine vendors, community pharmacists, private laboratories and other TB referral entities.”

Running on an Android mobile platform MATS provides real-time information through a web interface. People in communities, who approach private health providers, are screened with standard symptom checklists on the app. Thereafter, appropriate referrals or sample collection is initiated for the diagnosis and treatment of tuberculosis.

All of these are captured and viewed on the app by the private providers and Directly Observed Therapy (DOTs) providers in referral facilities. Since MATS was deployed, on the 1st of June 2020, there has already been a noticeable increase in the efficiency of referrals between facilities and community-based entities screening for TB. More than 19,000 individuals, across 20 states in Nigeria, have been screened leading to the identification of 1,286 presumptive tuberculosis cases, with 52 TB cases confirmed and placed on appropriate treatment.

The rollout across the 20 states is supported by the Global Fund under the TB Public Private Mix (PPM) grant which being implemented by IHVN and NTBLCP as principal recipients.

Dr. Obioma Chijioke-Akaniro, Monitoring and Evaluation Manager, NTBLCP, shares; “The simplicity of the app makes it attractive to the private sector especially as they may not oblige to filling cumbersome tools. Also, the cascade from total screened to identified TB cases is a remarkable way to see the effort put towards finding TB cases. After a few months on the field, we will take stock of what has worked, lessons learned, and also make adjustments if need be just as we make further plans for it.”

Share
Tags: Nigeria PharmAccess Technology UHC
Quickly go to
  • Home
  • Management & Board
  • Our partners
  • Reporting
  • Vacancies
  • Contact
  • Publications
Follow us
  • Twitter
  • Linkedin
  • Facebook
  • Home
  • Management & Board
  • Our partners
  • Reporting
  • Vacancies
  • Contact
  • Publications
  • Kenya
  • Nigeria
  • Ghana
  • Tanzania
  • Twitter
  • Linkedin
  • PharmAccess@Medium
  • Disclaimer
  • Privacy statement
  • © 2022 PharmAccess Group. All rights reserved.
Our COVID-19 response
To serve you better and more personal we make use of cookies.

Accept
Read more
Change Settings
Cookie Box Settings privacy settings
Cookie Box Settings privacy settings

Privacy settings

Decide which cookies you want to allow. You can change these settings at any time. However, this can result in some functions no longer being available. For information on deleting the cookies, please consult your browser’s help function. Learn more about the cookies we use via our privacy statement.

With the slider, you can enable or disable different types of cookies:

  • Block all
  • Essential
  • Functionality
  • Analytics

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected

This website won't:

  • Remember your login details
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country

This website won't:

  • Remember your login details
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settingsl Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions

This website won't:

  • Remember your login details
  • Advertising: Use information for tailored advertising with third parties
  • Advertising: Allow you to connect to social sites
  • Advertising: Identify device you are using
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settingsl Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Use information for tailored advertising with third parties
  • Advertising: Allow you to connect to social sitesl Advertising: Identify device you are using
  • Advertising: Gather personally identifiable information such as name and location

This website won't:

  • Remember your login details
Save & Close